Table 3.
Anti-Hypertensive Medication | No. of Cases | Person-Years | Age-Adjusted RR | 95% CI | Multivariable- Adjusted RR* | 95% CI |
---|---|---|---|---|---|---|
No Medication | 2,361 | 84,079 | 1.00 | Reference | 1.00 | Reference |
Thiazides | 917 | 24,991 | 1.21 | 1.12, 1.31 | 1.07 | 0.99, 1.16 |
Furosemide | 121 | 3,160 | 1.03 | 0.86, 1.24 | 0.91 | 0.75, 1.09 |
Calcium Channel Antagonists | 694 | 24,040 | 1.03 | 0.94, 1.12 | 1.01 | 0.93, 1.10 |
Beta Blockers | 1170 | 38,996 | 1.11 | 1.04, 1.19 | 1.01 | 0.94, 1.09 |
ACE Inhibitors | 881 | 30.288 | 1.12 | 1.04, 1.21 | 1.04 | 0.96, 1.13 |
Other Anti-Hypertensive Medication | 740 | 28,213 | 1.03 | 0.95, 1.12 | 1.00 | 0.92, 1.09 |
Multiple Anti-Hypertensive Medications | 3,590 | 101,804 | 1.15 | 1.09, 1.21 | 1.03 | 0.97, 1.08 |
RR denotes relative risk
Adjusted for age, race, body mass index, waist circumference, alcohol consumption, physical activity, nutrient (folate, magnesium, potassium, vitamin A, vitamin B12, vitamin C, vitamin E, beta-carotene, beta-cryptoxanthin, trans fat) intake, smoking status, hypertension, diabetes, tinnitus, and acetaminophen, aspirin, and ibuprofen use, and all the antihypertensive medications in the table.